相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Review: Activation patterns of microglia and their identification in the human brain
D. Boche et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update
Kelly R. Bales
EXPERT OPINION ON DRUG DISCOVERY (2012)
Localization of Mature Neprilysin in Lipid Rafts
Kimihiko Sato et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: a stochastic modelling approach
Carole J. Proctor et al.
MOLECULAR NEURODEGENERATION (2012)
Postsynaptic dysfunction is associated with spatial and object recognition memory loss in a natural model of Alzheimer's disease
Alvaro O. Ardiles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Aβ-Degrading Enzymes: Potential for Treatment of Alzheimer Disease
James Scott Miners et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Resveratrol Protects Rats from Aβ-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid Peroxidation
Tai-Chun Huang et al.
PLOS ONE (2011)
Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Aβ42 immunisation in Alzheimer's disease
Delphine Boche et al.
ACTA NEUROPATHOLOGICA (2010)
Neuropathology after active A beta 42 immunotherapy: implications for Alzheimer's disease pathogenesis
Delphine Boche et al.
ACTA NEUROPATHOLOGICA (2010)
Generation of reactive oxygen species by beta amyloid fibrils and oligomers involves different intra/extracellular pathways
Cenini Giovanna et al.
AMINO ACIDS (2010)
Protein aggregation containing beta-amyloid, alpha-synuclein and hyperphosphorylated tau in cultured cells of hippocampus, substantia nigra and locus coeruleus after rotenone exposure
Rodrigo S. Chaves et al.
BMC NEUROSCIENCE (2010)
Beneficial effect of human anti-amyloid-β active immunization on neurite morphology and tau pathology
Alberto Serrano-Pozo et al.
BRAIN (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Molecular mechanisms of neurodegeneration in Alzheimer's disease
Leslie Crews et al.
HUMAN MOLECULAR GENETICS (2010)
Amyloid-beta as a Modulator of Synaptic Plasticity
Mordhwaj S. Parihar et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy
Raquel Gomez-Sintes et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Juha O. Rinne et al.
LANCET NEUROLOGY (2010)
The biochemical aftermath of anti-amyloid immunotherapy
Chera L. Maarouf et al.
MOLECULAR NEURODEGENERATION (2010)
GSK3 and p53-is there a link in Alzheimer's disease?
Carole J. Proctor et al.
MOLECULAR NEURODEGENERATION (2010)
The benefits and limitations of animal models for translational research in neurodegenerative diseases
Mathias Jucker
NATURE MEDICINE (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Brains With Medial Temporal Lobe Neurofibrillary Tangles But No Neuritic Amyloid Plaques Are a Diagnostic Dilemma But May Have Pathogenetic Aspects Distinct From Alzheimer Disease
Peter T. Nelson et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
The role of tau in neurodegeneration
Tania F. Gendron et al.
MOLECULAR NEURODEGENERATION (2009)
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
S. Salloway et al.
NEUROLOGY (2009)
Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide
Xiaoyan Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
Aβ inhibits the proteasome and enhances amyloid and tau accumulation
Bertrand P. Tseng et al.
NEUROBIOLOGY OF AGING (2008)
Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo
John R. Cirrito et al.
NEURON (2008)
Linking Aβ and Tau in Late-Onset Alzheimer's Disease: A Dual Pathway Hypothesis
Scott A. Small et al.
NEURON (2008)
The GSK3 hypothesis of Alzheimer's disease
Claudie Hooper et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Amyloid-β precursor-like protein APLP1 is a novel p53 transcriptional target gene that augments neuroblastoma cell death upon genotoxic stress
X. Tang et al.
ONCOGENE (2007)
p53 is upregulated in Alzheimer's disease and induces tau phosphorylation in HEK293a cells
Claudie Hooper et al.
NEUROSCIENCE LETTERS (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation
Edward Rockenstein et al.
JOURNAL OF NEUROSCIENCE (2007)
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Richard S. Jope et al.
NEUROCHEMICAL RESEARCH (2007)
Solution state characterization of amyloid β-derived diffusible ligands
Robert W. Hepler et al.
BIOCHEMISTRY (2006)
COPASI- A COmplex PAthway SImulator
Stefan Hoops et al.
BIOINFORMATICS (2006)
Aβ species removal after Aβ42 immunization
James A. R. Nicoll et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Amyloid-β peptide remnants in AN-1792-immunized Alzheimer's disease patients -: A biochemical analysis
R. Lyle Patton et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
BioModels Database: a free, centralized database of curated, published, quantitative kinetic models of biochemical and cellular systems
Nicolas Le Novere et al.
NUCLEIC ACIDS RESEARCH (2006)
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer et al.
NEUROLOGY (2005)
Urea modulation of β-amyloid fibril growth:: Experimental studies and kinetic models
JR Kim et al.
PROTEIN SCIENCE (2004)
ABAD directly links Aβ to mitochondrial toxicity in Alzheimer's disease
JW Lustbader et al.
SCIENCE (2004)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
Glycogen synthase kinase-3β (GSK3β) binds to and promotes the actions of p53
P Watcharasit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Triple-transgenic model of Alzheimer's disease with plaques and tangles:: Intracellular Aβ and synaptic dysfunction
S Oddo et al.
NEURON (2003)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease
C Hock et al.
NEURON (2003)
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide:: a case report
JAR Nicoll et al.
NATURE MEDICINE (2003)
Immunotherapy for Alzheimer's disease
RC Dodel et al.
LANCET NEUROLOGY (2003)
The systems biology markup language (SBML):: a medium for representation and exchange of biochemical network models
M Hucka et al.
BIOINFORMATICS (2003)
A mathematical model of the impact of novel treatments on the Aβ burden in the Alzheimer's brain, CSF and plasma
DL Craft et al.
BULLETIN OF MATHEMATICAL BIOLOGY (2002)
Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage
P Watcharasit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Tau is essential to β-amyloid-induced neurotoxicity
M Rapoport et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A mathematical model of the kinetics of β-amyloid fibril growth from the denatured state
MM Pallitto et al.
BIOPHYSICAL JOURNAL (2001)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
分享论文
